Compound details
Incarvine C
| Compound ID | CDAMM01163 |
|---|---|
| Common name | Incarvine C | IUPAC name | (2,4,7-trimethyl-1,3,4,4a,5,6,7,7a-octahydrocyclopenta[c]pyridin-6-yl) 3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate |
| Molecular formula | C21H29NO4 |
| Retention time | 12.78 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 360.22 | Theoretical mz | 360.217 |
| Error | 6.17 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 6.4362 |
| Inchi key | OFDLBJAQGFWTKC-OVZXUKKZNA-N |
|---|---|
| Smiles | O=C(OC1CC2C(C)CN(C)CC2C1C)C=CC3=CC=C(O)C(OC)=C3 |
| Superclass | Phenylpropanoids and polyketides |
| Class | Cinnamic acids and derivatives |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P43681 | CHRNA4 | Neuronal acetylcholine receptor; alpha4/beta2 | T70967 | SwissTargetPrediction |
| P36544 | CHRNA7 | Neuronal acetylcholine receptor protein alpha-7 subunit | T34429 | SwissTargetPrediction |
| P29475 | NOS1 | Nitric-oxide synthase, brain | T16117 | SwissTargetPrediction |
| P29474 | NOS3 | Nitric-oxide synthase, endothelial | T06046 | SwissTargetPrediction |
| P09874 | PARP1 | Poly [ADP-ribose] polymerase-1 | T06273 | SwissTargetPrediction |
| Q99720 | SIGMAR1 | Sigma opioid receptor | T46360 | SwissTargetPrediction |
| P54289 | CACNA2D1 | Voltage-gated calcium channel alpha2/delta subunit 1 (by homology) | T84316 | SwissTargetPrediction |
| P21917 | DRD4 | Dopamine D4 receptor | T24983 | SwissTargetPrediction |
| P02766 | TTR | Transthyretin | T86462 | SEA |
| P05067 | APP | Beta amyloid A4 protein | T87024 | SEA |
| P14416 | DRD2 | Dopamine D2 receptor | T67162 | SwissTargetPrediction |
| P27487 | DPP4 | Dipeptidyl peptidase IV | T31391 | SwissTargetPrediction |
| Q05586 | GRIN1 | Glutamate NMDA receptor; GRIN1/GRIN2B | T62276 | SwissTargetPrediction |
| P43166 | CA7 | Carbonic anhydrase VII | T37541 | SEA |
| P23280 | CA6 | Carbonic anhydrase VI | T06569 | SEA |
| Q9ULX7 | CA14 | Carbonic anhydrase XIV | T31992 | SEA |
| P27338 | MAOB | Monoamine oxidase B | T83011 | SwissTargetPrediction |
| O60341 | KDM1A | Lysine-specific histone demethylase 1 | T16739 | SwissTargetPrediction |
| Q15118 | PDK1 | Pyruvate dehydrogenase kinase isoform 1 | T20891 | SwissTargetPrediction |
| P32297 | CHRNA3 | Neuronal acetylcholine receptor; alpha3/beta4 | T74166 | SwissTargetPrediction |
| P07949 | RET | Kinesin-1 heavy chain/ Tyrosine-protein kinase receptor RET | T60631 | SwissTargetPrediction |
| P50406 | HTR6 | Serotonin 6 (5-HT6) receptor | T16691 | SwissTargetPrediction |
| Q99705 | MCHR1 | Melanin-concentrating hormone receptor 1 | T09572 | SwissTargetPrediction |
| O75164 | KDM4A | Lysine-specific demethylase 4A | T18904 | SwissTargetPrediction |
| P11926 | ODC1 | Ornithine decarboxylase | T60366 | SEA |
| Q92731 | ESR2 | Estrogen receptor beta | T80896 | SwissTargetPrediction |
| P35968 | KDR | Vascular endothelial growth factor receptor 2 | T80975 | SwissTargetPrediction |
| O60885 | BRD4 | Bromodomain-containing protein 4 | T00407 | SwissTargetPrediction |
| O00519 | FAAH | Anandamide amidohydrolase | T11754 | SwissTargetPrediction |
| O14684 | PTGES | Prostaglandin E synthase | T02562 | SEA |
| P29350 | PTPN6 | Protein-tyrosine phosphatase 1C | T98264 | SEA |
| P49137 | MAPKAPK2 | MAP kinase-activated protein kinase 2 | T21307 | SwissTargetPrediction |
| Q9Y4C1 | KDM3A | Lysine-specific demethylase 3A | T25362 | SwissTargetPrediction |
| P21728 | DRD1 | Dopamine D1 receptor | T22118 | SwissTargetPrediction |
| P21918 | DRD5 | Dopamine D5 receptor | T46828 | SwissTargetPrediction |
| P33527 | ABCC1 | Multidrug resistance-associated protein 1 | T11288 | SwissTargetPrediction |
| P08183 | ABCB1 | P-glycoprotein 1 | T25258 | SwissTargetPrediction and SEA |
| P11309 | PIM1 | Serine/threonine-protein kinase PIM1 | T50594 | SwissTargetPrediction |
| Q15118 | PDK1 | Pyruvate dehydrogenase kinase isoform 1 | T20891 | SwissTargetPrediction |
| P42345 | MTOR | Serine/threonine-protein kinase mTOR | T75243 | SwissTargetPrediction |
| O14757 | CHEK1 | Serine/threonine-protein kinase Chk1 | T62449 | SwissTargetPrediction |
| P06276 | BCHE | Butyrylcholinesterase | T99799 | SEA |
| P30291 | WEE1 | Serine/threonine-protein kinase WEE1 | T69991 | SwissTargetPrediction |
| O60674 | JAK2 | Tyrosine-protein kinase JAK2 | T08391 | SwissTargetPrediction |
| P24941 | CDK2 | Cyclin-dependent kinase 2 | T70176 | SwissTargetPrediction |
| P11802 | CDK4 | Cyclin-dependent kinase 4 | T85799 | SwissTargetPrediction |
| Q9P1W9 | PIM2 | Serine/threonine-protein kinase PIM2 | T07279 | SwissTargetPrediction |
| Q86V86 | PIM3 | Serine/threonine-protein kinase PIM3 | T16596 | SwissTargetPrediction |
| O14965 | AURKA | Serine/threonine-protein kinase Aurora-A | T87675 | SwissTargetPrediction |
| Q9Y233 | PDE10A | Phosphodiesterase 10A (by homology) | T84133 | SwissTargetPrediction |
| P19838 | NFKB1 | Nuclear factor NF-kappa-B p105 subunit | T83145 | SEA |
| Q92847 | GHSR | Ghrelin receptor | T59604 | SwissTargetPrediction |
| Q13490 | BIRC2 | Baculoviral IAP repeat-containing protein 2 | T84780 | SwissTargetPrediction |
| P11137 | MAP2 | Microtubule-associated protein 2 | T23276 | SwissTargetPrediction |
| P11388 | TOP2A | DNA topoisomerase II alpha | T17048 | SEA |
| O75460 | ERN1 | Serine/threonine-protein kinase/endoribonuclease IRE1 | T01003 | SwissTargetPrediction |
| Q9UHL4 | DPP7 | Dipeptidyl peptidase II | T50773 | SwissTargetPrediction |
| P35348 | ADRA1A | Alpha-1a adrenergic receptor | T92609 | SwissTargetPrediction |
| O75116 | ROCK2 | Rho-associated protein kinase 2 | T06093 | SwissTargetPrediction |
| P23458 | JAK1 | Tyrosine-protein kinase JAK1 | T62460 | SwissTargetPrediction |
| P31749 | AKT1 | Serine/threonine-protein kinase AKT | T67619 | SwissTargetPrediction |
| Q09472 | EP300 | Histone acetyltransferase p300 | T25956 | SEA |
| P05771 | PRKCB | Protein kinase C beta | T40276 | SwissTargetPrediction |
| P08581 | MET | Hepatocyte growth factor receptor | T40474 | SwissTargetPrediction and SEA |
| P41229 | KDM5C | Lysine-specific demethylase 5C | T85540 | SwissTargetPrediction |
| P17948 | FLT1 | Vascular endothelial growth factor receptor 1 | T63966 | SwissTargetPrediction |
| P12931 | SRC | Tyrosine-protein kinase SRC | T85943 | SwissTargetPrediction |
| Q9UGN5 | PARP2 | Poly [ADP-ribose] polymerase 2 | T40812 | SwissTargetPrediction |
| P52333 | JAK3 | Tyrosine-protein kinase JAK3 | T23172 | SwissTargetPrediction |
| Q9NWZ3 | IRAK4 | Interleukin-1 receptor-associated kinase 4 | T55398 | SwissTargetPrediction |
| Q9UGL1 | KDM5B | Lysine-specific demethylase 5B | T56871 | SwissTargetPrediction |
| Q9Y2K7 | KDM2A | Lysine-specific demethylase 2A | T71949 | SwissTargetPrediction |
| P23443 | RPS6KB1 | Ribosomal protein S6 kinase 1 | T94479 | SwissTargetPrediction |
| P09619 | PDGFRB | Platelet-derived growth factor receptor beta | T59102 | SwissTargetPrediction |
| P11362 | FGFR1 | Fibroblast growth factor receptor 1 | T47101 | SwissTargetPrediction |
| P06493 | CDK1 | Cyclin-dependent kinase 1/cyclin B1 | T49898 | SwissTargetPrediction |
| P50613 | CDK7 | Cyclin-dependent kinase 7 | T58449 | SwissTargetPrediction |
| P42574 | CASP3 | Caspase-3 | T57943 | SwissTargetPrediction |
| P30874 | SSTR2 | Somatostatin receptor 2 | T53024 | SwissTargetPrediction |
| P48736 | PIK3CG | PI3-kinase p110-gamma subunit | T95913 | SwissTargetPrediction |
| Q6V1X1 | DPP8 | Dipeptidyl peptidase VIII | T15855 | SwissTargetPrediction |
| Q86TI2 | DPP9 | Dipeptidyl peptidase IX | T66252 | SwissTargetPrediction |
| P30968 | GNRHR | Gonadotropin-releasing hormone receptor | T12475 | SwissTargetPrediction |
| Q96GD4 | AURKB | Serine/threonine-protein kinase Aurora-B | T46781 | SwissTargetPrediction |
| Q9UNQ0 | ABCG2 | ATP-binding cassette sub-family G member 2 | T56556 | SEA |
| Q9UHD2 | TBK1 | Serine/threonine-protein kinase TBK1 | T63024 | SwissTargetPrediction |
| P43490 | NAMPT | Nicotinamide phosphoribosyltransferase | T54582 | SwissTargetPrediction |
| P25106 | ACKR3 | C-X-C chemokine receptor type 7 | T10491 | SwissTargetPrediction |
| Q9UKP6 | UTS2R | Urotensin II receptor | T49072 | SwissTargetPrediction |
| Q14680 | MELK | Maternal embryonic leucine zipper kinase | T96892 | SwissTargetPrediction |
| Q15746 | MYLK | Myosin light chain kinase, smooth muscle | T97141 | SwissTargetPrediction |
| P10636 | MAPT | Microtubule-associated protein tau | T45593 | SEA |
| Q04760 | GLO1 | Glyoxalase I | T88285 | SEA |
| P61964 | WDR5 | WD repeat-containing protein 5 | T77393 | SwissTargetPrediction |
| P20248 | CCNA2 | CDK2/Cyclin A | T58470 | SwissTargetPrediction |
| Q06418 | TYRO3 | Tyrosine-protein kinase receptor TYRO3 | T94880 | SwissTargetPrediction |
| Q05513 | PRKCZ | Protein kinase C (PKC) | T59190 | SwissTargetPrediction |
| P35790 | CHKA | Choline kinase alpha | T55709 | SwissTargetPrediction |
| P05129 | PRKCG | Protein kinase C gamma | T47107 | SwissTargetPrediction |
| P49682 | CXCR3 | C-X-C chemokine receptor type 3 | T25315 | SwissTargetPrediction |
| O96013 | PAK4 | Serine/threonine-protein kinase PAK 4 | T98293 | SwissTargetPrediction |
| P19438 | TNFRSF1A | Tumor necrosis factor receptor R1 | T86552 | SEA |
| Q16236 | NFE2L2 | Nuclear factor erythroid 2-related factor 2 | T88505 | SEA |
| Q6PL18 | ATAD2 | ATPase family AAA domain-containing protein 2 | T82467 | SwissTargetPrediction |
| P47901 | AVPR1B | Vasopressin V1b receptor | T59881 | SwissTargetPrediction |
| Q9NY47 | CACNA2D2 | Voltage-gated calcium channel alpha2/delta subunit 2 | T28132 | SwissTargetPrediction |
| P48048 | KCNJ1 | ATP-sensitive inward rectifier potassium channel 1 | T78710 | SwissTargetPrediction |
| Q13698 | CACNA1S | Voltage-gated L-type calcium channel alpha-1S subunit | T24965 | SwissTargetPrediction |
| Q9Y345 | SLC6A5 | Glycine transporter 2 | T58937 | SwissTargetPrediction |
| Q9H4B7 | TUBB1 | Tubulin beta-1 chain | T84397 | SEA |
| O43826 | SLC37A4 | Glucose-6-phosphate translocase | T47306 | SEA |
| Q15349 | RPS6KA2 | Ribosomal protein S6 kinase alpha 2 | T28043 | SwissTargetPrediction |
| P11717 | IGF2R | Insulin-like growth factor II receptor | T59550 | SEA |
| P32249 | EBI2 | EBV-induced G-protein coupled receptor 2 | T59577 | SEA |
| P01100 | FOS | Proto-oncogene c-Fos | T28025 | SEA |
| Q9NR20 | DYRK4 | Dual-specificity tyrosine-phosphorylation regulated kinase 4 | T20542 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T70967 | DI0029 | Aneurysm/dissection | [ICD-11: BD50] | P43681 | CHRNA4 |
| T70967 | DI0191 | Hypertensive crisis | [ICD-11: BA03] | P43681 | CHRNA4 |
| T70967 | DI0196 | Hypotension | [ICD-11: BA20-BA21] | P43681 | CHRNA4 |
| T34429 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | P36544 | CHRNA7 |
| T34429 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P36544 | CHRNA7 |
| T16117 | DI0173 | Headache | [ICD-11: 8A80-8A84] | P29475 | NOS1 |
| T16117 | DI0264 | Migraine | [ICD-11: 8A80] | P29475 | NOS1 |
| T06046 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | P29474 | NOS3 |
| T06273 | DI0006 | Acquired cutaneous blood vessel malformation | [ICD-11: EF20] | P09874 | PARP1 |
| T06273 | DI0143 | Fallopian tube cancer | [ICD-11: 2C74] | P09874 | PARP1 |
| T06273 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | P09874 | PARP1 |
| T06273 | DI0334 | Peritoneal cancer | [ICD-11: 2C51] | P09874 | PARP1 |
| T46360 | DI0105 | Cough | [ICD-11: MD12] | Q99720 | SIGMAR1 |
| T84316 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P54289 | CACNA2D1 |
| T84316 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P54289 | CACNA2D1 |
| T24983 | DI0022 | Allergic/hypersensitivity disorder | [ICD-11: 4A80-4A8Z] | P21917 | DRD4 |
| T24983 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P21917 | DRD4 |
| T86462 | DI0026 | Amyloidosis | [ICD-11: 5D00] | P02766 | TTR |
| T87024 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P05067 | APP |
| T87024 | DI0122 | Diagnostic imaging | [ICD-11: N.A.] | P05067 | APP |
| T67162 | DI0022 | Allergic/hypersensitivity disorder | [ICD-11: 4A80-4A8Z] | P14416 | DRD2 |
| T67162 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P14416 | DRD2 |
| T67162 | DI0037 | Asthma | [ICD-11: CA23] | P14416 | DRD2 |
| T67162 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P14416 | DRD2 |
| T67162 | DI0051 | Bipolar disorder | [ICD-11: 6A60] | P14416 | DRD2 |
| T67162 | DI0063 | Breathing abnormality | [ICD-11: MD11] | P14416 | DRD2 |
| T67162 | DI0070 | Cardiovascular disease | [ICD-11: BA00-BE2Z] | P14416 | DRD2 |
| T67162 | DI0073 | Cerebral ischaemia | [ICD-11: 8B1Z] | P14416 | DRD2 |
| T67162 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P14416 | DRD2 |
| T67162 | DI0124 | Digestive system disease | [ICD-11: DE2Z] | P14416 | DRD2 |
| T67162 | DI0137 | Essential hypertension | [ICD-11: BA00] | P14416 | DRD2 |
| T67162 | DI0142 | Faecal incontinence | [ICD-11: ME07] | P14416 | DRD2 |
| T67162 | DI0156 | Gangrene | [ICD-11: MC85] | P14416 | DRD2 |
| T67162 | DI0166 | Glaucoma | [ICD-11: 9C61] | P14416 | DRD2 |
| T67162 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P14416 | DRD2 |
| T67162 | DI0185 | Hyperaemia | [ICD-11: 9A61-9B7Y] | P14416 | DRD2 |
| T67162 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P14416 | DRD2 |
| T67162 | DI0196 | Hypotension | [ICD-11: BA20-BA21] | P14416 | DRD2 |
| T67162 | DI0205 | Inborn porphyrin/heme metabolism error | [ICD-11: 5C58] | P14416 | DRD2 |
| T67162 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P14416 | DRD2 |
| T67162 | DI0222 | Itching | [ICD-11: 1F28-1G07] | P14416 | DRD2 |
| T67162 | DI0264 | Migraine | [ICD-11: 8A80] | P14416 | DRD2 |
| T67162 | DI0293 | Nausea/vomiting | [ICD-11: MD90] | P14416 | DRD2 |
| T67162 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P14416 | DRD2 |
| T67162 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P14416 | DRD2 |
| T67162 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P14416 | DRD2 |
| T67162 | DI0340 | Postpartum haemorrhage | [ICD-11: JA43] | P14416 | DRD2 |
| T67162 | DI0354 | Psychotic disorder | [ICD-11: 6A20-6A25] | P14416 | DRD2 |
| T67162 | DI0356 | Pulmonary hypertension | [ICD-11: BB01] | P14416 | DRD2 |
| T67162 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P14416 | DRD2 |
| T67162 | DI0396 | Substance abuse | [ICD-11: 6C40] | P14416 | DRD2 |
| T67162 | DI0408 | Thyrotoxicosis | [ICD-11: 5A02] | P14416 | DRD2 |
| T67162 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P14416 | DRD2 |
| T31391 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P27487 | DPP4 |
| T31391 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P27487 | DPP4 |
| T62276 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | Q05586 | GRIN1 |
| T62276 | DI0182 | HIV-infected patients with tuberculosis | [ICD-11: 1B10-1B14] | Q05586 | GRIN1 |
| T06569 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | P23280 | CA6 |
| T06569 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P23280 | CA6 |
| T31992 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | Q9ULX7 | CA14 |
| T31992 | DI0204 | Inborn metabolism deficiency | [ICD-11: 5C50-5C59] | Q9ULX7 | CA14 |
| T83011 | DI0115 | Dementia | [ICD-11: 6D80-6D8Z] | P27338 | MAOB |
| T83011 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P27338 | MAOB |
| T83011 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P27338 | MAOB |
| T83011 | DI0243 | Malaria | [ICD-11: 1F40-1F45] | P27338 | MAOB |
| T83011 | DI0264 | Migraine | [ICD-11: 8A80] | P27338 | MAOB |
| T83011 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P27338 | MAOB |
| T16739 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | O60341 | KDM1A |
| T16739 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | O60341 | KDM1A |
| T16739 | DI0138 | Ewing sarcoma | [ICD-11: 2B52] | O60341 | KDM1A |
| T16739 | DI0238 | Lung cancer | [ICD-11: 2C25] | O60341 | KDM1A |
| T16739 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | O60341 | KDM1A |
| T16739 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | O60341 | KDM1A |
| T16739 | DI0284 | Myelodysplastic syndrome | [ICD-11: 2A37] | O60341 | KDM1A |
| T16739 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | O60341 | KDM1A |
| T16739 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O60341 | KDM1A |
| T20891 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | Q15118 | PDK1 |
| T74166 | DI0105 | Cough | [ICD-11: MD12] | P32297 | CHRNA3 |
| T60631 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P07949 | RET |
| T60631 | DI0238 | Lung cancer | [ICD-11: 2C25] | P07949 | RET |
| T60631 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | P07949 | RET |
| T60631 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P07949 | RET |
| T60631 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P07949 | RET |
| T60631 | DI0407 | Thyroid cancer | [ICD-11: 2D10] | P07949 | RET |
| T16691 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P50406 | HTR6 |
| T16691 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P50406 | HTR6 |
| T09572 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | Q99705 | MCHR1 |
| T60366 | DI0020 | African trypanosomiasis | [ICD-11: 1F51] | P11926 | ODC1 |
| T80896 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | Q92731 | ESR2 |
| T80896 | DI0108 | Cushing syndrome | [ICD-11: 5A70] | Q92731 | ESR2 |
| T80896 | DI0254 | Menopausal disorder | [ICD-11: GA30] | Q92731 | ESR2 |
| T80896 | DI0432 | Vasomotor/allergic rhinitis | [ICD-11: CA08] | Q92731 | ESR2 |
| T80975 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P35968 | KDR |
| T80975 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P35968 | KDR |
| T80975 | DI0160 | Gastrointestinal stromal tumour | [ICD-11: 2B5B] | P35968 | KDR |
| T80975 | DI0244 | Malignant digestive organ neoplasm | [ICD-11: 2C11] | P35968 | KDR |
| T80975 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P35968 | KDR |
| T80975 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P35968 | KDR |
| T80975 | DI0395 | Stomach cancer | [ICD-11: 2B72] | P35968 | KDR |
| T80975 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P35968 | KDR |
| T80975 | DI0407 | Thyroid cancer | [ICD-11: 2D10] | P35968 | KDR |
| T11754 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | O00519 | FAAH |
| T02562 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | O14684 | PTGES |
| T21307 | DI0011 | Acute laryngitis/tracheitis | [ICD-11: CA05] | P49137 | MAPKAPK2 |
| T21307 | DI0181 | Hidradenitis suppurativa | [ICD-11: ED92] | P49137 | MAPKAPK2 |
| T21307 | DI0269 | Monogenic autoinflammatory syndrome | [ICD-11: 4A60] | P49137 | MAPKAPK2 |
| T21307 | DI0334 | Peritoneal cancer | [ICD-11: 2C51] | P49137 | MAPKAPK2 |
| T21307 | DI0352 | Psoriatic arthritis | [ICD-11: FA21] | P49137 | MAPKAPK2 |
| T21307 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P49137 | MAPKAPK2 |
| T21307 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P49137 | MAPKAPK2 |
| T22118 | DI0003 | Abortion | [ICD-11: JA00] | P21728 | DRD1 |
| T22118 | DI0022 | Allergic/hypersensitivity disorder | [ICD-11: 4A80-4A8Z] | P21728 | DRD1 |
| T22118 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P21728 | DRD1 |
| T22118 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P21728 | DRD1 |
| T46828 | DI0022 | Allergic/hypersensitivity disorder | [ICD-11: 4A80-4A8Z] | P21918 | DRD5 |
| T11288 | DI0167 | Gout | [ICD-11: FA25] | P33527 | ABCC1 |
| T25258 | DI0238 | Lung cancer | [ICD-11: 2C25] | P08183 | ABCB1 |
| T50594 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P11309 | PIM1 |
| T50594 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P11309 | PIM1 |
| T20891 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | Q15118 | PDK1 |
| T75243 | DI0036 | Arteries/arterioles disorder | [ICD-11: BD52] | P42345 | MTOR |
| T75243 | DI0085 | Chronic myelomonocytic leukaemia | [ICD-11: 2A40] | P42345 | MTOR |
| T75243 | DI0274 | Multiple myeloma | [ICD-11: 2A83] | P42345 | MTOR |
| T75243 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P42345 | MTOR |
| T75243 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P42345 | MTOR |
| T75243 | DI0413 | Transplant rejection | [ICD-11: NE84] | P42345 | MTOR |
| T62449 | DI0027 | Anal cancer | [ICD-11: 2C00] | O14757 | CHEK1 |
| T62449 | DI0172 | Head and neck cancer | [ICD-11: 2D42] | O14757 | CHEK1 |
| T62449 | DI0183 | Hodgkin lymphoma | [ICD-11: 2B30] | O14757 | CHEK1 |
| T62449 | DI0238 | Lung cancer | [ICD-11: 2C25] | O14757 | CHEK1 |
| T62449 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | O14757 | CHEK1 |
| T62449 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | O14757 | CHEK1 |
| T62449 | DI0326 | Pancreatic cancer | [ICD-11: 2C10] | O14757 | CHEK1 |
| T62449 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O14757 | CHEK1 |
| T99799 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P06276 | BCHE |
| T99799 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | P06276 | BCHE |
| T69991 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | P30291 | WEE1 |
| T69991 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P30291 | WEE1 |
| T69991 | DI0429 | Uterine ligament/parametrium/uterine adnexa neoplasm | [ICD-11: 2C72] | P30291 | WEE1 |
| T08391 | DI0039 | Atopic eczema | [ICD-11: EA80] | O60674 | JAK2 |
| T08391 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | O60674 | JAK2 |
| T08391 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | O60674 | JAK2 |
| T08391 | DI0404 | Thrombocytosis | [ICD-11: 3B63] | O60674 | JAK2 |
| T70176 | DI0060 | Brain cancer | [ICD-11: 2A00] | P24941 | CDK2 |
| T70176 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P24941 | CDK2 |
| T70176 | DI0238 | Lung cancer | [ICD-11: 2C25] | P24941 | CDK2 |
| T70176 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | P24941 | CDK2 |
| T70176 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P24941 | CDK2 |
| T70176 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | P24941 | CDK2 |
| T70176 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P24941 | CDK2 |
| T70176 | DI0406 | Thymoma | [ICD-11: 2C27] | P24941 | CDK2 |
| T85799 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P11802 | CDK4 |
| T85799 | DI0238 | Lung cancer | [ICD-11: 2C25] | P11802 | CDK4 |
| T85799 | DI0351 | Psoriasis | [ICD-11: EA90] | P11802 | CDK4 |
| T07279 | DI0274 | Multiple myeloma | [ICD-11: 2A83] | Q9P1W9 | PIM2 |
| T07279 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9P1W9 | PIM2 |
| T87675 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | O14965 | AURKA |
| T87675 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O14965 | AURKA |
| T84133 | DI0079 | Choreiform disorder | [ICD-11: 8A01] | Q9Y233 | PDE10A |
| T84133 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | Q9Y233 | PDE10A |
| T84133 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | Q9Y233 | PDE10A |
| T84133 | DI0370 | Schizophrenia | [ICD-11: 6A20] | Q9Y233 | PDE10A |
| T84133 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9Y233 | PDE10A |
| T83145 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | P19838 | NFKB1 |
| T83145 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P19838 | NFKB1 |
| T59604 | DI0087 | Chronic pain | [ICD-11: MG30] | Q92847 | GHSR |
| T59604 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | Q92847 | GHSR |
| T84780 | DI0259 | Metastatic lymph node neoplasm | [ICD-11: 2D60] | Q13490 | BIRC2 |
| T23276 | DI0036 | Arteries/arterioles disorder | [ICD-11: BD52] | P11137 | MAP2 |
| T23276 | DI0252 | Melanoma | [ICD-11: 2C30] | P11137 | MAP2 |
| T23276 | DI0326 | Pancreatic cancer | [ICD-11: 2C10] | P11137 | MAP2 |
| T23276 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P11137 | MAP2 |
| T17048 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P11388 | TOP2A |
| T17048 | DI0225 | Kaposi sarcoma | [ICD-11: 2B57] | P11388 | TOP2A |
| T17048 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P11388 | TOP2A |
| T01003 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | O75460 | ERN1 |
| T92609 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P35348 | ADRA1A |
| T92609 | DI0348 | Prostate hyperplasia | [ICD-11: GA90] | P35348 | ADRA1A |
| T06093 | DI0168 | Graft-versus-host disease | [ICD-11: 4B24] | O75116 | ROCK2 |
| T62460 | DI0039 | Atopic eczema | [ICD-11: EA80] | P23458 | JAK1 |
| T62460 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P23458 | JAK1 |
| T62460 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P23458 | JAK1 |
| T62460 | DI0404 | Thrombocytosis | [ICD-11: 3B63] | P23458 | JAK1 |
| T67619 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P31749 | AKT1 |
| T25956 | DI0346 | Prostate cancer | [ICD-11: 2C82] | Q09472 | EP300 |
| T25956 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q09472 | EP300 |
| T40276 | DI0123 | Diffuse large B-cell lymphoma | [ICD-11: 2A81] | P05771 | PRKCB |
| T40276 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | P05771 | PRKCB |
| T40276 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P05771 | PRKCB |
| T40474 | DI0238 | Lung cancer | [ICD-11: 2C25] | P08581 | MET |
| T40474 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | P08581 | MET |
| T40474 | DI0407 | Thyroid cancer | [ICD-11: 2D10] | P08581 | MET |
| T63966 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P17948 | FLT1 |
| T85943 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P12931 | SRC |
| T85943 | DI0220 | Ischemia | [ICD-11: 8B10-8B11] | P12931 | SRC |
| T85943 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P12931 | SRC |
| T85943 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P12931 | SRC |
| T40812 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | Q9UGN5 | PARP2 |
| T40812 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9UGN5 | PARP2 |
| T23172 | DI0023 | Alopecia | [ICD-11: ED70] | P52333 | JAK3 |
| T23172 | DI0039 | Atopic eczema | [ICD-11: EA80] | P52333 | JAK3 |
| T23172 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P52333 | JAK3 |
| T23172 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P52333 | JAK3 |
| T55398 | DI0039 | Atopic eczema | [ICD-11: EA80] | Q9NWZ3 | IRAK4 |
| T55398 | DI0109 | Cutaneous lupus erythematosus | [ICD-11: EB50-EB5Z] | Q9NWZ3 | IRAK4 |
| T55398 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | Q9NWZ3 | IRAK4 |
| T55398 | DI0339 | Postoperative inflammation | [ICD-11: 1A00-CA43] | Q9NWZ3 | IRAK4 |
| T55398 | DI0351 | Psoriasis | [ICD-11: EA90] | Q9NWZ3 | IRAK4 |
| T55398 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q9NWZ3 | IRAK4 |
| T94479 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P23443 | RPS6KB1 |
| T94479 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P23443 | RPS6KB1 |
| T94479 | DI0419 | Ulcerative colitis | [ICD-11: DD71] | P23443 | RPS6KB1 |
| T59102 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P09619 | PDGFRB |
| T59102 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P09619 | PDGFRB |
| T59102 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P09619 | PDGFRB |
| T47101 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P11362 | FGFR1 |
| T47101 | DI0199 | Idiopathic interstitial pneumonitis | [ICD-11: CB03] | P11362 | FGFR1 |
| T47101 | DI0235 | Liver cancer | [ICD-11: 2C12] | P11362 | FGFR1 |
| T47101 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P11362 | FGFR1 |
| T49898 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P06493 | CDK1 |
| T49898 | DI0238 | Lung cancer | [ICD-11: 2C25] | P06493 | CDK1 |
| T49898 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P06493 | CDK1 |
| T49898 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | P06493 | CDK1 |
| T49898 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P06493 | CDK1 |
| T58449 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P50613 | CDK7 |
| T58449 | DI0238 | Lung cancer | [ICD-11: 2C25] | P50613 | CDK7 |
| T58449 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P50613 | CDK7 |
| T58449 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P50613 | CDK7 |
| T57943 | DI0060 | Brain cancer | [ICD-11: 2A00] | P42574 | CASP3 |
| T53024 | DI0108 | Cushing syndrome | [ICD-11: 5A70] | P30874 | SSTR2 |
| T53024 | DI0122 | Diagnostic imaging | [ICD-11: N.A.] | P30874 | SSTR2 |
| T53024 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P30874 | SSTR2 |
| T95913 | DI0151 | Follicular lymphoma | [ICD-11: 2A80] | P48736 | PIK3CG |
| T95913 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P48736 | PIK3CG |
| T95913 | DI0249 | Mature B-cell leukaemia | [ICD-11: 2A82] | P48736 | PIK3CG |
| T15855 | DI0300 | Neutropenia | [ICD-11: 4B00] | Q6V1X1 | DPP8 |
| T66252 | DI0300 | Neutropenia | [ICD-11: 4B00] | Q86TI2 | DPP9 |
| T12475 | DI0130 | Endometriosis | [ICD-11: GA10] | P30968 | GNRHR |
| T12475 | DI0322 | Ovarian developmental anomaly | [ICD-11: LB45] | P30968 | GNRHR |
| T12475 | DI0323 | Ovarian dysfunction | [ICD-11: 5A80] | P30968 | GNRHR |
| T12475 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P30968 | GNRHR |
| T12475 | DI0346 | Prostate cancer | [ICD-11: 2C82] | P30968 | GNRHR |
| T12475 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P30968 | GNRHR |
| T46781 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | Q96GD4 | AURKB |
| T46781 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q96GD4 | AURKB |
| T56556 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | Q9UNQ0 | ABCG2 |
| T56556 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q9UNQ0 | ABCG2 |
| T54582 | DI0231 | Leukaemia | [ICD-11: 2A60-2B33] | P43490 | NAMPT |
| T54582 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | P43490 | NAMPT |
| T54582 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P43490 | NAMPT |
| T10491 | DI0037 | Asthma | [ICD-11: CA23] | P25106 | ACKR3 |
| T10491 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P25106 | ACKR3 |
| T49072 | DI0037 | Asthma | [ICD-11: CA23] | Q9UKP6 | UTS2R |
| T96892 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | Q14680 | MELK |
| T96892 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | Q14680 | MELK |
| T96892 | DI0249 | Mature B-cell leukaemia | [ICD-11: 2A82] | Q14680 | MELK |
| T96892 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | Q14680 | MELK |
| T96892 | DI0284 | Myelodysplastic syndrome | [ICD-11: 2A37] | Q14680 | MELK |
| T96892 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | Q14680 | MELK |
| T97141 | DI0127 | Duodenal ulcer | [ICD-11: DA63] | Q15746 | MYLK |
| T45593 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P10636 | MAPT |
| T45593 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P10636 | MAPT |
| T45593 | DI0265 | Mild neurocognitive disorder | [ICD-11: 6D71] | P10636 | MAPT |
| T88285 | DI0210 | Influenza | [ICD-11: 1E30-1E32] | Q04760 | GLO1 |
| T58470 | DI0363 | Retina cancer | [ICD-11: 2D02] | P20248 | CCNA2 |
| T94880 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q06418 | TYRO3 |
| T59190 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q05513 | PRKCZ |
| T55709 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P35790 | CHKA |
| T47107 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P05129 | PRKCG |
| T47107 | DI0248 | Mastocytosis | [ICD-11: 2A21] | P05129 | PRKCG |
| T25315 | DI0178 | Hepatic fibrosis/cirrhosis | [ICD-11: DB93] | P49682 | CXCR3 |
| T25315 | DI0339 | Postoperative inflammation | [ICD-11: 1A00-CA43] | P49682 | CXCR3 |
| T25315 | DI0351 | Psoriasis | [ICD-11: EA90] | P49682 | CXCR3 |
| T25315 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P49682 | CXCR3 |
| T98293 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | O96013 | PAK4 |
| T98293 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O96013 | PAK4 |
| T86552 | DI0060 | Brain cancer | [ICD-11: 2A00] | P19438 | TNFRSF1A |
| T86552 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | P19438 | TNFRSF1A |
| T88505 | DI0038 | Ataxic disorder | [ICD-11: 8A03] | Q16236 | NFE2L2 |
| T59881 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P47901 | AVPR1B |
| T59881 | DI0041 | Autism spectrum disorder | [ICD-11: 6A02] | P47901 | AVPR1B |
| T59881 | DI0194 | Hypo-osmolality/hyponatraemia | [ICD-11: 5C72] | P47901 | AVPR1B |
| T84397 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9H4B7 | TUBB1 |
| T28043 | DI0249 | Mature B-cell leukaemia | [ICD-11: 2A82] | Q15349 | RPS6KA2 |
| T59550 | DI0146 | Fibrosis | [ICD-11: GA14-GC01] | P11717 | IGF2R |
| T59550 | DI0368 | Sarcoidosis | [ICD-11: 4B20] | P11717 | IGF2R |